Insider Transactions in Q1 2025 at Life Stance Health Group, Inc. (LFST)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2025
|
Ryan Mc Groarty |
BUY
Grant, award, or other acquisition
|
Direct |
184,911
+25.24%
|
-
|
|
Mar 17
2025
|
Lisa K Miller |
SELL
Open market or private sale
|
Direct |
18,845
-5.25%
|
$113,070
$6.9 P/Share
|
|
Mar 10
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,650
-1.03%
|
$57,900
$6.63 P/Share
|
|
Mar 10
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Open market or private sale
|
Indirect |
15,605
-2.9%
|
$109,235
$7.64 P/Share
|
|
Mar 07
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Open market or private sale
|
Indirect |
19,900
-3.57%
|
$139,300
$7.29 P/Share
|
|
Mar 07
2025
|
David Bourdon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
72,501
-4.03%
|
$507,507
$7.59 P/Share
|
|
Mar 07
2025
|
David Bourdon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
205,550
+10.2%
|
-
|
|
Mar 07
2025
|
Kenneth A Burdick |
SELL
Payment of exercise price or tax liability
|
Direct |
278,192
-4.04%
|
$1,947,344
$7.59 P/Share
|
|
Mar 07
2025
|
Kenneth A Burdick |
BUY
Grant, award, or other acquisition
|
Direct |
706,962
+9.3%
|
-
|
|
Mar 07
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,554
-1.46%
|
$304,878
$7.59 P/Share
|
|
Mar 07
2025
|
Pablo Pantaleoni Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,343
+4.48%
|
-
|
|
Mar 07
2025
|
Ann Varanakis Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,331
-1.62%
|
$86,317
$7.59 P/Share
|
|
Mar 07
2025
|
Ann Varanakis Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,792
+7.38%
|
-
|
|
Mar 07
2025
|
Ryan Pardo |
SELL
Payment of exercise price or tax liability
|
Direct |
41,825
-2.23%
|
$292,775
$7.59 P/Share
|
|
Mar 07
2025
|
Ryan Pardo |
BUY
Grant, award, or other acquisition
|
Direct |
137,484
+6.77%
|
-
|
|
Mar 07
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,544
-4.66%
|
$45,808
$7.59 P/Share
|
|
Mar 07
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,805
+12.91%
|
-
|
|
Mar 06
2025
|
David Bourdon Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,767
-2.14%
|
$117,369
$7.88 P/Share
|
|
Mar 06
2025
|
David Bourdon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
348,985
+30.83%
|
-
|
|
Mar 06
2025
|
Kenneth A Burdick |
SELL
Payment of exercise price or tax liability
|
Direct |
53,602
-1.77%
|
$375,214
$7.88 P/Share
|
|
Mar 06
2025
|
Kenneth A Burdick |
BUY
Grant, award, or other acquisition
|
Direct |
95,178
+3.05%
|
-
|
|
Mar 06
2025
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,444
-1.37%
|
$136,108
$7.88 P/Share
|
|
Mar 06
2025
|
Pablo Pantaleoni Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117,386
+7.65%
|
-
|
|
Mar 06
2025
|
Lisa K Miller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,431
-1.76%
|
$45,017
$7.88 P/Share
|
|
Mar 06
2025
|
Lisa K Miller |
BUY
Grant, award, or other acquisition
|
Direct |
76,142
+17.26%
|
-
|
|
Mar 06
2025
|
Ann Varanakis Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,455
-1.9%
|
$45,185
$7.88 P/Share
|
|
Mar 06
2025
|
Ann Varanakis Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,142
+18.33%
|
-
|
|
Mar 06
2025
|
Ryan Pardo |
SELL
Payment of exercise price or tax liability
|
Direct |
18,919
-2.2%
|
$132,433
$7.88 P/Share
|
|
Mar 06
2025
|
Ryan Pardo |
BUY
Grant, award, or other acquisition
|
Direct |
114,213
+11.72%
|
-
|
|
Mar 06
2025
|
Ujjwal Ramtekkar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,107
+32.33%
|
-
|